Skip to content

Research landscape

The shape of ME/CFS research, in numbers.

Every figure on this page is a direct count of the 6,211 public atlas records. Design tiers, PEM status and domain assignment are machine labels derived from abstracts — useful for orientation, not a substitute for reading the studies.

1 · Timeline

Studies per publication year

Stacked by study design tier. The rise after 2020 reflects both Long COVID research and broader indexing of recent literature.

The current year is incomplete.

02004001980: 3 studies — E0 0, E1 0, E2 1, E3 219801981: 0 studies — E0 0, E1 0, E2 0, E3 01982: 0 studies — E0 0, E1 0, E2 0, E3 01983: 1 studies — E0 0, E1 0, E2 0, E3 11984: 2 studies — E0 0, E1 0, E2 1, E3 11985: 3 studies — E0 0, E1 0, E2 0, E3 31986: 2 studies — E0 0, E1 0, E2 1, E3 11987: 4 studies — E0 0, E1 0, E2 2, E3 21988: 23 studies — E0 0, E1 1, E2 6, E3 161989: 18 studies — E0 0, E1 1, E2 6, E3 111990: 28 studies — E0 0, E1 2, E2 10, E3 1619901991: 83 studies — E0 1, E1 1, E2 22, E3 591992: 75 studies — E0 0, E1 2, E2 24, E3 491993: 64 studies — E0 1, E1 2, E2 27, E3 341994: 98 studies — E0 0, E1 2, E2 48, E3 481995: 90 studies — E0 0, E1 0, E2 50, E3 401996: 114 studies — E0 0, E1 7, E2 52, E3 551997: 112 studies — E0 1, E1 7, E2 55, E3 491998: 124 studies — E0 0, E1 7, E2 69, E3 481999: 115 studies — E0 0, E1 3, E2 53, E3 592000: 98 studies — E0 2, E1 2, E2 57, E3 3720002001: 123 studies — E0 5, E1 9, E2 50, E3 592002: 144 studies — E0 6, E1 7, E2 65, E3 662003: 126 studies — E0 3, E1 5, E2 67, E3 512004: 143 studies — E0 3, E1 16, E2 66, E3 582005: 137 studies — E0 6, E1 9, E2 66, E3 562006: 131 studies — E0 5, E1 5, E2 58, E3 632007: 144 studies — E0 7, E1 6, E2 51, E3 802008: 140 studies — E0 8, E1 7, E2 70, E3 552009: 160 studies — E0 8, E1 8, E2 82, E3 622010: 181 studies — E0 5, E1 14, E2 92, E3 7020102011: 214 studies — E0 14, E1 12, E2 114, E3 742012: 185 studies — E0 5, E1 10, E2 89, E3 812013: 183 studies — E0 11, E1 21, E2 78, E3 732014: 155 studies — E0 16, E1 9, E2 63, E3 672015: 202 studies — E0 15, E1 18, E2 92, E3 772016: 188 studies — E0 14, E1 13, E2 89, E3 722017: 189 studies — E0 16, E1 22, E2 91, E3 602018: 210 studies — E0 16, E1 5, E2 101, E3 882019: 212 studies — E0 15, E1 7, E2 99, E3 912020: 217 studies — E0 31, E1 8, E2 100, E3 7820202021: 291 studies — E0 32, E1 8, E2 119, E3 1322022: 269 studies — E0 19, E1 7, E2 124, E3 1192023: 306 studies — E0 30, E1 12, E2 133, E3 1312024: 305 studies — E0 36, E1 21, E2 111, E3 1372025: 369 studies — E0 33, E1 14, E2 160, E3 1622026: 206 studies — E0 31, E1 10, E2 110, E3 55
E0 · Evidence synthesisE1 · Randomised trialE2 · Observational studyE3 · Other / exploratory
Show the numbers
YearE0E1E2E3Total
2026311011055206
20253314160162369
20243621111137305
20233012133131306
2022197124119269
2021328119132291
202031810078217
20191579991212
201816510188210
201716229160189
201614138972188
201515189277202
20141696367155
201311217873183
20125108981185
2011141211474214
20105149270181
2009888262160
2008877055140
2007765180144
2006555863131
2005696656137
20043166658143
2003356751126
2002676566144
2001595059123
200022573798
1999035359115
1998076948124
1997175549112
1996075255114
199500504090
199402484898
199312273464
199202244975
199111225983
199002101628
19890161118
19880161623
198700224
198600112
198500033
198400112
198300011
198200000
198100000
198000123

Study design mix

How the 6,211 public studies in this atlas split by study-design tier. The tier describes the kind of study, assigned by machine from the abstract. It is not a quality rating and does not mean a finding has been replicated.

2 · Evidence map

Research domains × study design tier

Bubble area is the share of each domain’s studies at that level. Select a count to open those studies.

Lowest share of reviews or replicated studies (E0–E1): Metabolic Dysfunction, Immune Dysregulation, Neuroinflammation.

A study can belong to several domains; 15 domains in total.

Public studies per research domain and study design tier. Each count links to those studies in the evidence explorer.
Research domainE0SynthesisE1RandomisedE2ObservationalE3OtherStudiesPEM req.
Immune Dysregulation4534460672
1211
6%
Post-Exertional Malaise5716316359
748
43%
Diagnostics380230274
542
5%
Cognitive Impairment2118249119
407
5%
Autonomic Nervous System1711209126
363
3%
Biomarkers184190100
312
12%
Sleep Dysfunction211915784
281
2%
Pain and Sensitization1413126102
255
2%
Interventions42525476
224
2%
Metabolic Dysfunction8573128
214
7%
Neuroinflammation11134137
183
8%
Endocrine Disruption1055564
134
0%
Long COVID Overlap814228
79
4%
Gut Microbiome831221
44
5%
Severe ME311019
33
36%

3 · Case definition

How often did cohorts require post-exertional malaise?

Among ME/CFS, post-infectious and overlapping-population studies from the last five years, 17% are labelled as having required PEM for inclusion.

“Unclear” usually means the abstract does not state the criteria — not that PEM was absent. Criteria that do not require PEM (e.g. Oxford, Fukuda) can include people without ME/CFS as defined today. Why criteria matter

2000: 86 studies — PEM required 0, unclear 22, not required 6420002001: 104 studies — PEM required 1, unclear 27, not required 762002: 129 studies — PEM required 2, unclear 35, not required 922003: 110 studies — PEM required 0, unclear 22, not required 882004: 130 studies — PEM required 1, unclear 26, not required 1032005: 124 studies — PEM required 1, unclear 37, not required 8620052006: 113 studies — PEM required 0, unclear 31, not required 822007: 126 studies — PEM required 4, unclear 25, not required 972008: 126 studies — PEM required 0, unclear 33, not required 932009: 147 studies — PEM required 2, unclear 28, not required 1172010: 166 studies — PEM required 4, unclear 52, not required 11020102011: 175 studies — PEM required 5, unclear 59, not required 1112012: 159 studies — PEM required 3, unclear 57, not required 992013: 149 studies — PEM required 6, unclear 45, not required 982014: 132 studies — PEM required 5, unclear 49, not required 782015: 181 studies — PEM required 21, unclear 49, not required 11120152016: 164 studies — PEM required 13, unclear 68, not required 832017: 172 studies — PEM required 16, unclear 70, not required 862018: 181 studies — PEM required 15, unclear 84, not required 822019: 186 studies — PEM required 23, unclear 85, not required 782020: 184 studies — PEM required 25, unclear 96, not required 6320202021: 245 studies — PEM required 36, unclear 135, not required 742022: 206 studies — PEM required 36, unclear 104, not required 662023: 243 studies — PEM required 49, unclear 123, not required 712024: 235 studies — PEM required 35, unclear 135, not required 652025: 284 studies — PEM required 60, unclear 148, not required 7620252026: 164 studies — PEM required 19, unclear 121, not required 24
PEM required (bottom)Unclear from abstractNot required (top)

4 · Relationships

Which domains are studied together

Number of studies assigned to both domains, and what share of the smaller domain that represents.

Overlap means the same studies address both areas. It does not show a biological or causal link.

  1. Immune Dysregulation and Post-Exertional Malaise121 studies · 16% of the smaller domain
  2. Biomarkers and Immune Dysregulation112 studies · 36% of the smaller domain
  3. Neuroinflammation and Immune Dysregulation79 studies · 43% of the smaller domain
  4. Pain and Sensitization and Sleep Dysfunction46 studies · 18% of the smaller domain
  5. Metabolic Dysfunction and Immune Dysregulation42 studies · 20% of the smaller domain
  6. Autonomic Nervous System and Cognitive Impairment40 studies · 11% of the smaller domain
  7. Sleep Dysfunction and Cognitive Impairment40 studies · 14% of the smaller domain
  8. Biomarkers and Post-Exertional Malaise39 studies · 13% of the smaller domain
  9. Pain and Sensitization and Cognitive Impairment37 studies · 15% of the smaller domain
  10. Metabolic Dysfunction and Post-Exertional Malaise30 studies · 14% of the smaller domain
  11. Neuroinflammation and Post-Exertional Malaise25 studies · 14% of the smaller domain
  12. Neuroinflammation and Biomarkers25 studies · 14% of the smaller domain
  13. Biomarkers and Metabolic Dysfunction24 studies · 11% of the smaller domain
  14. Gut Microbiome and Immune Dysregulation23 studies · 52% of the smaller domain

5 · Paradigm

Research paradigm over time

Biomedical, psychosomatic and neutral framing of studies by year (machine label; 3-year rolling average).

Research paradigm over time

How the share of biomedical vs. psychosomatic vs. neutral research has changed year by year within the 6,211 public studies in this atlas. Values are a 3-year rolling average of the paradigm mix by publication year, not raw counts.

This describes the atlas’s corpus composition over time, not the overall ME/CFS research field. The “biomedical” bucket is a classifier-assigned label for studies with explicitly biomedical framing; many biologically relevant observational and review studies sit in “neutral” instead. Studies without a publication year in 1990–2026 are not plotted. How we classify paradigms →

0%25%50%75%100%199019952000200520102015202020253-year rolling average(partial)
Biomedical 71%Psychosomatic 10%Neutral 19% (dashed)
Data table
YearBiomedical %Psychosomatic %Neutral %
1990502525
1991532126
1992552025
1993621622
1994611920
1995612020
1996562222
1997602119
1998582122
1999581922
2000542125
2001532423
2002542422
2003532521
2004552322
2005552321
2006582120
2007572320
2008562420
2009572221
2010602020
2011631819
2012612118
2013622216
2014572419
2015582121
2016562123
2017621820
2018631720
2019661520
2020651421
2021671221
2022691021
2023681022
2024691120
2025691021
2026711019

Data: public ME/CFS Atlas records, recomputed hourly. Download the underlying records from the evidence explorer (CSV/JSON export). Methodology